Glycated Haemoglobin Testing Market is segmented By Product Type (Laboratory-based analyzers, Point of Care (POC) analyzers), By Technology (Immunoass....
Market Size in USD
CAGR8.6%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.6% |
Market Concentration | High |
Major Players | Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Tosoh Corporation, Bio-Rad Laboratories |
The glycated haemoglobin testing market is estimated to be valued at USD 239 Mn in 2024 and is expected to reach USD 426 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
The glycated haemoglobin testing market is expected to witness significant growth over the forecast period. The market is driven by rising diabetes prevalence across the globe. As per WHO, the global diabetes cases are expected to double from current 422 million to over 700 million by 2045. Rising obese population is another factor augmenting the risk of diabetes, thereby propelling demand for regular blood sugar monitoring tests such as glycated haemoglobin testing.